Intralesional steroid injectionIntralesional steroid injection involves a corticosteroid, such as triamcinolone acetonide or betamethasone suspension, which is injected directly into a lesion on or immediately below keloid scar steroid injection skin. In Keliod Zealand triamcinolone is marketed as Kenacort-A, and is available in 2 strengths: Triamcinolone acetonide is marketed as Kenalog in the USA. Betamethasone injection is tren tay x100s as Celestone Chronodose 1 mL. Shorter-acting corticosteroid preparations, such as dexamethasone or betamethasone acetate, are sometimes administered in combination with triamcinolone.
Intralesional steroid injection | DermNet New Zealand
Intralesional steroid injection involves a corticosteroid, such as triamcinolone acetonide or betamethasone suspension, which is injected directly into a lesion on or immediately below the skin. In New Zealand triamcinolone is marketed as Kenacort-A, and is available in 2 strengths: Triamcinolone acetonide is marketed as Kenalog in the USA. Betamethasone injection is marketed as Celestone Chronodose 1 mL. Shorter-acting corticosteroid preparations, such as dexamethasone or betamethasone acetate, are sometimes administered in combination with triamcinolone.
Intralesional administration of corticosteroids is used to treat a dermal inflammatory process directly. In contrast to topical steroids , intralesional steroids:. Triamcinolone is also sometimes used intramuscularly as an alternative to oral corticosteroids , for example for seasonal hay fever, or to treat a chronic skin disorder such as atopic dermatitis or lichen planus.
Typical intramuscular doses are 0. Triamcinolone injections can also be used in the treatment of tendonitis, arthritis and synovitis. Intralesional steroids should not be injected at the site of active skin infection e. They must not be used if there is a previous history of triamcinolone hypersensitivity allergy.
When large doses of triamcinolone acetonide injections are used as an alternative to oral steroids such as prednisone, they are considered to be systemic steroids. These should be avoided in patients with the following disorders. Intralesional triamcinolone is injected directly into the skin lesion using a fine needle after cleaning the site of injection with alcohol or antiseptic solution.
The injection should be intradermal, not subcutaneous, to avoid causing a dent in the skin. The initial dose per injection site will vary depending on the lesion being treated. The total dose should not normally exceed 1 or 2 mL per dose. It can be repeated every 4 to 8 weeks. Typical regimes for triamcinolone intralesional injections include:. Side effects and risks of intralesional triamcinolone may be separated into early and delayed effects. Other systemic side-effects are not likely to follow intralesional injection of localised skin disease because the dose used is very small.
However, the following potentially serious conditions have been reported from intramuscular injection of large doses of triamcinolone acetonide.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice. New Zealand approved datasheets are the official source of information for these prescription medicines, including approved uses and risk information. Check the individual New Zealand datasheet on the Medsafe website. Accessed 26th Feb Surgery of the Skin — Procedural Dermatology, 2nd Edition.
Corticosteroid Injections of Joints and Soft Tissues. Accessed 26 Feb Systemic steroids Topical steroids Other websites: See the DermNet NZ bookstore.